Abaloparatide Real‐World Patient Experience Study-Reference-Cited by-同舟云学术

Abaloparatide Real‐World Patient Experience Study

Published:2021-02-04 Issue:3 Volume:5 Page:
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Gold Deborah T¹,Weiss Richard²,Beckett Tammy³,Deal Chad⁴,Epstein Robert S⁵,James Andrew L⁶,Kernaghan Jacqueline M⁷,Mohseni Mahshid⁸,Spiegel Michael⁹,Vokes Tamara¹⁰,Roberts Jenna¹¹,Bailey Tom¹¹,Wang Yamei¹²,Williams Setareh A¹³^ORCID

Affiliation:

1. Departments of Psychiatry & Behavioral Sciences and Sociology Duke University Medical Center Durham NC USA

2. Global Medical Affairs Radius Health, Inc. Waltham MA USA

3. Department of Orthopaedics Orthopaedic Associates of Grand Rapids Research and Education Institute Grand Rapids MI USA

4. Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatology The Cleveland Clinic Foundation Cleveland OH USA

5. Epstein Health, LLC Woodcliff Lake NJ USA

6. Adult Health CNS Proactive Orthopaedics Proactive Orthopaedics at Columbia Orthopaedic Groups LLP Columbia MO USA

7. Osteoporosis Center of Delaware County Prospect Health Access Network Springfield PA USA

8. Department of Medicine, Division of Bone and Mineral Diseases Washington University School of Medicine St Louis MO USA

9. WCMG Rheumatology Western Connecticut Health Network Danbury CT USA

10. Department of Medicine, Section of Endocrinology University of Chicago Chicago IL USA

11. Observational Research Adelphi Real World Bollington, Macclesfield UK

12. Biometrics Radius Health, Inc. Waltham, MA USA

13. Health Economics and Outcomes Research Radius Health, Inc. Waltham, MA USA

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm4.10457

Reference27 articles.

1. International Osteoporosis Foundation (IOF). Facts and Statistics. Nyon Switzerland IOF; 2020 [cited 2020 Dec 27]. Available from:https://www.iofbonehealth.org/facts-statistics#category-14.

2. Institute for Clinical and Economic Review (ICER). Osteoporosis. Boston MA: ICER; 2017 [cited 2020 Dec 27]. Available from:https://icer-review.org/topic/osteoporosis/.

3. Clinician’s Guide to Prevention and Treatment of Osteoporosis

4. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

5. Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abaloparatid – eine neue osteoanabole Therapieoption für die Osteoporose bei postmenopausalen Frauen;Osteologie;2024-07-10

2. A crossover comparison of patient satisfaction with two teriparatide regimens: primary results of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06);Journal of Bone and Mineral Metabolism;2024-06-11

3. Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study;Osteoporosis International;2024-04-24

4. Skin in the Game?;Journal of Bone and Mineral Research;2023-09-14

5. Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States;PharmacoEconomics;2023-04-22